Seneca Biopharma Inc. Stock News

GERMANTOWN, Md., April 26, 2021 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA) ("Seneca" or the "Company"), disclosed on April 23, 2021, the passing of the final proposal required for approval

Privately-held Leading BioSciences Inc entered into a definitive agreement for a reverse merger with Seneca Biopharma Inc (NASDAQ: SNCA) has announced data from an open-label gastrointestinal

GERMANTOWN, Md., April 12, 2021 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA) ("Seneca" or the "Company"), announced the preliminary voting results of its Special Meeting of Stockholders on A

The stock price of Seneca Biopharma Inc (NASDAQ: SNCA) increased by over 20% pre-market. This is why it happened.

Video message explains the multiple benefits of the proposed merger and provides an overview of the substantial market opportunity for the combined company to be named Palisade Bio

GERMANTOWN, Md., March 24, 2021 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA) (the "Company") today announced that the Company adjourned its special meeting of stockholders scheduled for Wedn

The stock price of Seneca Biopharma Inc (NASDAQ: SNCA) fell by over 4% pre-market. This is why it happened.

GERMANTOWN, Md., March 22, 2021 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, toda

Seneca Biopharma (SNCA) stock is on the rise as investors prepare for an upcoming meeting covering a merger and reverse stock split. The post SNCA Stock: Seneca Biopharma Shares Rocket Ahead of Merger

The stock price of Seneca Biopharma Inc (NASDAQ: SNCA) has increased by over 80% during pre-market trading. This is why it happened.

The stock price of Seneca Biopharma (NASDAQ: SNCA) has increased by over 30% pre-market. This is why it happened.

GERMANTOWN, Md., March 17, 2021 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), today announced that leading independent proxy advisory firm Institutional Shareholder Services, Inc. ("ISS") ha

Week In Review: Suzhou's Adagene To Stage $125 Million IPO On NASDAQ

Regeneron Pharmaceuticals (NASDAQ: REGN) shares are trading higher after the company announced an additional U.S. order to purchase 1.25 million doses of its COVID-19 antibody cocktail bringing the to

NEW YORK, Dec. 23, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Buildingin New York Ci